CIK 0001176309
- Non-accelerated filer
- Smaller reporting company
ORAMED PHARMACEUTICALS INC.
Sign in to watch- Ticker
- ORMP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 980376008
- Phone
- +1 646-844-1164
- Business address
- 1185 AVENUE OF THE AMERICAS, 3RD FLOOR, NEW YORK, NY, 10036
- Former names
- Integrated Security Technologies, Inc., IGUANA VENTURES LTD
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $225,530
- in 2 filings, $226K under 10b5-1 plans
Net −$225,530. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 59 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-12 | KIDRON NADAV President and CEO | Grant or award | +629,000 | 4,769,505 | ||
| 2026-11-12 | KIDRON NADAV President and CEO | Grant or award | +688,000 | 5,457,505 | ||
| 2026-09-24 | KIDRON NADAV President and CEO | Grant or award | +349,497 | 3,771,740 | ||
| 2026-09-24 | KIDRON NADAV President and CEO | Grant or award | +368,765 | 4,140,505 | ||
| 2026-09-24 | KIDRON NADAV President and CEO | Returned to the company · Stock option (right to buy) | −196,500 | 0 | ||
| 2026-09-24 | KIDRON NADAV President and CEO | Returned to the company · Stock option (right to buy) | −190,000 | 0 | ||
| 2026-09-24 | KIDRON NADAV President and CEO | Returned to the company · Stock option (right to buy) | −49,000 | 0 | ||
| 2026-09-24 | KIDRON NADAV President and CEO | Returned to the company · Stock option (right to buy) | −97,000 | 0 | ||
| 2026-09-24 | KIDRON NADAV President and CEO | Returned to the company · Stock option (right to buy) | −150,000 | 0 | ||
| 2026-09-24 | KIDRON NADAV President and CEO | Returned to the company · Stock option (right to buy) | −107,000 | 0 | ||
| 2026-03-30 | KIDRON NADAV President and CEO | Shares withheld for taxes | −44,818 | $3.31 | $148K | 3,422,243 |
| 2026-03-17 | KIDRON NADAV President and CEO | Grant or award | +167,005 | 3,422,243 | ||
| 2026-03-12 | KIDRON NADAV President and CEO | Gift | −100,000 | 3,255,238 | ||
| 2026-01-22 | KIDRON NADAV President and CEO | Option exercise | +109,000 | 3,355,238 | ||
| 2026-01-22 | KIDRON NADAV President and CEO | Option exercise · Performance Stock Units | −109,000 | 0 | ||
| 2025-12-31 | KIDRON NADAV President and CEO | Grant or award | +232,640 | 2,919,238 | ||
| 2025-12-31 | KIDRON NADAV President and CEO | Grant or award | +327,000 | 3,246,238 | ||
| 2025-12-31 | KIDRON NADAV President and CEO | Grant or award · Performance Stock Units | +109,000 | 109,000 | ||
| 2025-02-11 | KIDRON NADAV President and CEO | Grant or award | +141,000 | 2,400,598 | ||
| 2025-02-11 | KIDRON NADAV President and CEO | Grant or award | +186,000 | 2,586,598 |
Page 1 of 4 · 70 trades